98
CORRÊA, D. H. A.; MELO, P. S.; CARVALHO, C. A. A. de.; AZEVEDO, M. B. M. de.;
DURÁN, N.; HAUN, M. Dehydrocrotonin and its β-cyclodextrin complex: cytotoxicity in
V79 fibroblasts and rat cultured hepatocytes. Eur. J. Pharmacol
.
, v. 510, p. 17-24, 2005.
CROOM, K. F.; GOA, K. L. Levofloxacin – a review of its use in the treatment of bacterial
infections in the United States. Drugs, v.
63, p. 2769-2802, 2003.
DAVIS, R.; BRYSON, H. M. Levofloxacin. A review of its antibacterial activity,
pharmacokinetics and therapeutic efficacy. Drugs, v.
47, p. 677-700, 1994.
DE AZEVEDO, M. M. M. Nanoesferas e a liberação sustentada de fármacos. Monografia,
Laboratório de Química do Estado Sólido (LQES), Universidade Estadual de Campinas
(UNICAMP), 2003. Disponível em: <http://Iqes.iqm.unicamp.br>. Acesso em: 09 jun. 2004.
DENIZOT, F.; LANG, R. Rapid colorimetric assay for cell growth and survival, modifications to
the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol.
Methods., v. 89, p. 271-277, 1986.
DONBROW, M. Microcapsules ans nanoparticles in medicine and pharmacy. Boca Raton:
CRC,1991, 163 p.
DONG, Y.; FENG, S. Methoxy poly (ethylene glycol)-poly (lactide) (MPEG-PLA) nanoparticles
for controlled delivery of anticancer drugs. Biomaterials, v. 25, p. 2843-2849, 2004.
DUNN. R. L. Polymeric matrices. Inn: DUNN, R. L.; OTTEMBRITE, R. M. Polymeric drugs
and drug delivery systems. Am. Chem. Soc., Washington, DC, p. 10-23, 1991.
EISENBRAND, G.; POOL-ZOBEL, B.; BAKER, V.; BALLS, M.; BLAAUBOER, B. J.;
BOOBIS, A.; CARERE, A.; KEVEKORDES, S.; LHUGUENOT, J., C.; PIETERS, R.;
KLEINER, J. Methods of in vitro toxicology.
Food Chem. Toxicol., v. 40, p. 193-236, 2002.